Home Biosimilar Antibodies Others Others antibody Ravulizumab (Anti-Complement C5) For research use only.
Not for use in humans.

Ravulizumab (Anti-Complement C5)

Synonyms: ALXN1210

Ravulizumab (Anti-Complement C5) is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis. MW: 145.5 KD.

Ravulizumab (Anti-Complement C5)

Purity & Quality Control

Batch: A253701 Purity: 99% Protein concentration: 8.63mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Ravulizumab (Anti-Complement C5) is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis. MW: 145.5 KD.

Product Details

CAS No. 1803171-55-2
Molecular Weight 145.5 kDa
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ravulizumab (Anti-Complement C5) | Ravulizumab (Anti-Complement C5) supplier | purchase Ravulizumab (Anti-Complement C5) | Ravulizumab (Anti-Complement C5) cost | Ravulizumab (Anti-Complement C5) manufacturer | order Ravulizumab (Anti-Complement C5) | Ravulizumab (Anti-Complement C5) distributor